Takeda Pharmaceuticals America, Inc.
Takeda Pharmaceutical Company Limited is a global, research-driven biopharmaceutical company focusing on gastroenterology, rare diseases, neuroscience, oncology, and plasma-derived therapies. Takeda Pharmaceuticals America, Inc. is the U.S. affiliate of Takeda, supporting research, development, and commercialization of Takeda's medicines in the American market.
Layoff history
EMPLOYEES AFFECTED PER QUARTER · HOVER FOR DETAILS
Layoff timeline
3 EVENTSCompany, a major defense contractor, has announced that it will lay off 227 employees in Maryland. This decision reflects ongoing adjustments within the company, although specific reasons for the layoffs were not detailed in the article. The layoffs are part of a broader trend affecting the defense industry, but the exact impact on Company’s operations remains to be seen. The affected employees will be notified shortly, and the company is expected to provide further details on the situation.
Takeda Pharmaceuticals in Cambridge, identified as the state's largest life sciences employer, filed a WARN notice planning to cut 247 jobs beginning July 1 and continuing through the end of the year. The WARN filing also noted plans to eliminate 387 positions in other states, though Takeda's U.S. employment counsel said those numbers may change as employees pursue redeployment within Takeda’s global network and that the company will supplement notices if impacts evolve. The article places these planned cuts among nearly 1,392 Massachusetts layoffs expected in August and notes that WARN counts can change if sales or redeployments occur. Takeda emphasized potential changes to the figures and its intent to remain transparent if additional impacts are identified.
Stories from here
No one has shared a story from Takeda yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Takeda
We'll email you the moment a new layoff is reported here.